Home›Companies›CytoTronics

CytoTronics, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 11, 2024·Suggest an edit

About CytoTronics

CytoTronics is a private company based in Boston, Massachusetts, incorporated in 2020 in Delaware. It has reported $13,500,000 raised in one offering on Form D since October 2024. Its chief executive is Jeffrey Abbott.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 22, 2024Oct 11, 2024$13,500,000fully sold10$1.3MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on CytoTronics's Form D filed Oct 11, 2024.

SR
JA
Jeffrey Abbott
Chief Executive Officer and director
DK
Douglas Kahn
Director
WW
Wenxuan Wu
Executive officer and director
JA
Jenna Abelli
Director

Sources

  1. SECCytoTronics, Inc. filing history